Brett A Grimaud - 02 Apr 2024 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, GEN COUNSEL AND SECRETARY
Signature
/s/ Brett A. Grimaud
Issuer symbol
TBPH
Transactions as of
02 Apr 2024
Net transactions value
$0
Form type
4
Filing time
04 Apr 2024, 18:11:50 UTC
Previous filing
22 Feb 2024
Next filing
22 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Award $0 +100,000 +38% $0.000000 360,684 02 Apr 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 2, 2024, the reporting person was granted 100,000 RSUs. 37,500 RSUs are subject to service-based vesting conditions and the remaining 62,500 RSUs vest based on the achievement of share price appreciation targets as well as continued employment.